In non-neuroendocrine related tumors such as in hepatocellular carcinoma cells, npy1r inhibit cell proliferation by activating mitogen-activated protein kinase signal pathway, promoting tumor growth and increasing tumorigenicity of cells (Lv et al., 2016). Here, WNK2 is linked to hepatocellular carcinoma.